Summary
This MSCA-IF project has addressed a challenging objective: the presence of the blood-brain barrier (BBB) has limited the treatments of neurological diseases since it constrains the drug delivery to the brain. Although novel nanomedicines have emerged as promising alternatives...
More information & hyperlinks
Web resources: | https://energia.imdea.org/en/porfolio/6468/ |